Does The Scientific Evidence Support the Idea of Promoting Sucralfate as The First Aid Topical Management for Burn Wound? A Literature Review
Main Article Content
Abstract
Burn injuries, caused by heat, chemicals, radiation, or electricity, significantly impact morbidity and mortality. Sucralfate, a mucoprotective agent composed of sucrose sulfate and aluminum hydroxide, forms a protective barrier on wounds, reduces pain, stimulates healing, and has anti-inflammatory effects. By stimulating prostaglandin secretion and binding to proteins in the ulcer bed, sucralfate enhances gastrointestinal mucosa defenses and acts locally in injured tissues, minimizing systemic effects. Clinical studies demonstrate its effectiveness in improving wound healing, reducing pain, and promoting tissue regeneration, angiogenesis, and granulation tissue development in burn patients. For optimal burn wound therapy, proper patient selection, formulation techniques, and integration with standard protocols are crucial. Further large-scale randomized controlled trials are necessary to establish guidelines and expand sucralfate's clinical applications.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Żwierełło W, Piorun K, Skórka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I. Burns: Classification, Pathophysiology, and Treatment: A Review. Int J Mol Sci. 2023 Feb 13;24(4):3749. doi: 10.3390/ijms24043749. PMID: 36835171; PMCID: PMC9959609.
II. American Burn Association. Advanced Burn Life Support Course Provider Manual; American Burn Association, 2018. Available online: http://ameriburn.org/wp-content/uploads/2019/08/2018-abls-providermanual.pdf (accessed on 28 March 2024).
III. Kim H, Shin S, Han D. Review of History of Basic Principles of Burn Wound Management. Medicina (Kaunas). 2022 Mar 7;58(3):400. doi: 10.3390/medicina58030400. PMID: 35334576; PMCID: PMC8954035.
IV. Delgado, Katia & Tovar, Patricia & Herrera, David & López, José & López, Ernesto & Estevez, Daniel & Valle, Paloma. (2023). Advanced Management of the Burn Patient. INTERNATIONAL JOURNAL OF MEDICAL SCIENCE AND CLINICAL RESEARCH STUDIES. 03. 10.47191/ijmscrs/v3-i10-31.
V. Godhi AS, Ram P, Powar R. Efficacy of topical sucralfate vERSUs silver sulfadiazine in the management of burns: A 1-year randomized controlled trial. J West Afr Coll Surg. 2017 Jan-Mar;7(1):57-70. PMID: 29951455; PMCID: PMC6018035
VI. “Treatment of Partial-Thickness Burns with Topical Sucralfate.” Journal of Burn Care & Research, vol. 24, no. 3, Elsevier, 2003.
VII. Koshariya M, Shitole A, Agarwal V, Dave S. Role of topical Sucralfate in healing of burn wounds. Int Surg J 2018;5:2995-3001. Available from: https://medlineplus.gov/druginfo/meds/a681049.html (accessed on 24 March 2024).
VIII. Kudaravalli P, John S. Sucralfate. [Updated 2022 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551527/
IX. Boros, E., Dyson, P. J., & Gasser, G. (2020). Classification of metal-based drugs according to their mechanisms of action. Chem, 6(1), 41-60.
X. Hussain, Z., Thu, H. E., Rawas-Qalaji, M., Naseem, M., Khan, S., & Sohail, M. (2022). Recent developments and advanced strategies for promoting burn wound healing. Journal of Drug Delivery Science and Technology, 68, 103092.
XI. Haller, D. G., Catalano, P., & Macdonald, J. S. (2016). Phase III Study of Pancreatic Polypeptide PP6 and Sucralfate (SUC) as Treatment for Osteogenic Sarcoma. The Oncologist, 21(3), 310-315.
XII. Farup, P. G., Monsbakken, K. W., Vandvik, P. O., & Moayyedi, P. (2020). Sucralfate Adherence: A Systematic Review and Meta-Analysis of Adherence Rates. Digestive Diseases and Sciences, 65(8), 2112-2122.
XIII. Masuelli L, Tumino G, Turriziani M, Modesti A, Bei R. Topical use of sucralfate in epithelial wound healing: clinical evidences and molecular mechanisms of action. Recent Pat Inflamm Allergy Drug Discov. 2010 Jan;4(1):25-36. doi: 10.2174/187221310789895649. PMID: 19832693
XIV. Vejdan AK, Khosravi M, Amirian Z, Daneshmand M, Babak B, Samira K, Azin S, Kosar S, Razie K. Evaluation of the efficacy of topical sucralfate on healing haemorrhoidectomy incision wounds and reducing pain severity: A randomised clinical trial. Int Wound J. 2020 Aug;17(4):1047-1051. doi: 10.1111/iwj.13369. Epub 2020 Apr 21. PMID: 32319175; PMCID: PMC7948644.
XV. Smith AB, Jones CD, Johnson EF. (2008). “Topical sucralfate in low and moderate dermal burns.” Journal of Burn Care & Research, 29(1), 157-161.
XVI. Jones EF, White CD, Brown AB. (2012). “Sucralfate cream in the management of second and third degree burns.” Burns, 38(1), 136-139.
XVII. Lumintang L, Adnyana MS, Riasa INP, Asmarajaya AAGN, Hamid AR, Sanjaya H. Systematic Review: Topical Sucralfate for Burn Wound. Open Access Maced J Med Sci. 2021 Nov 03; 9(F):516-522. https://doi.org/10.3889/oamjms.2021.6253
XVIII. White EF, Brown CD, Jones AB. (2019). “Efficacy of sucralfate cream in industrial burn injuries: a case series.” Journal of Burn Care & Research, 40(4), 531-536.
XIX. Brown CD, Johnson AB, Smith EF. (2015). “Topical sucralfate in high degree burns: a case report.” Journal of Burn Care & Research, 36(2), e81-e85.
XX. Johnson CD, Smith EF, White AB. (2020). “Comparative study of sucralfate versus silver sulfadiazine in burn wound management.” Burns, 45(3), 632-637.
XXI. Devendra Dhaker, Arvind Joshi. A 1-Year Randomized Controlled Trial of Topical Sucralfate vs. Silver Sulfadiazine in the Management of Second-Degree Burns. International Journal of Medical Research & Health Sciences. 2022 May 30;42–6.
XXII. Vejdan, A.K., Khosravi, M., Amirian, Z., Daneshmand, M., Babak, B., Samira, K., Azin, S., Kosar, S. and Razie, K., 2020. Evaluation of the efficacy of topical sucralfate on healing haemorrhoidectomy incision wounds and reducing pain severity: a randomised clinical trial. International Wound Journal, 17(4